Implantable Cardioverter-Defibrillator for Primary Prevention in Asia Posted on June 16th, 2023 by LEADconnection Post navigation Previous: 3-Dimensional Printing for Planning for Transvenous Pacemaker Placement in Complex Congenital Heart DiseaseNext: Philips and BIOTRONIK expand care for out-of-hospital cardiology labs with new strategic alliance
3-Dimensional Printing for Planning for Transvenous Pacemaker Placement in Complex Congenital Heart Disease Posted on June 13th, 2023 by LEADconnection Post navigation Previous: A Randomized Trial of Lenient Versus Strict Arm Instruction Post Cardiac Device Surgery (LENIENT).Next: Implantable Cardioverter-Defibrillator for Primary Prevention in Asia
A Randomized Trial of Lenient Versus Strict Arm Instruction Post Cardiac Device Surgery (LENIENT). Posted on June 13th, 2023 by LEADconnection Post navigation Previous: Complex cardiac implantable electronic device infections in Alberta, Canada: An epidemiologic cohort study of validated administrative data.Next: 3-Dimensional Printing for Planning for Transvenous Pacemaker Placement in Complex Congenital Heart Disease